EUVIMEDEUVIMED entdecken
Open Access · CC0

Combined oral contraceptive utilization and uterine fibroid incidence: A prospective study in a cohort of African-American women

Sarah R Hoffman iD, Jennifer S Smith, Michele Jonsson Funk, Michael G Hudgens, Charles Poole, Wanda K Nicholson, Donna D Baird, Quaker E Harmon iD

PLOS ONE · 23.05.2024 · 19 (5) · e0303823

DOI: 10.1371/journal.pone.0303823 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 23.05.2024. Verfasst von Sarah R Hoffman und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, University of North Carolina Gillings School of Global Public Health, Chapel Hill, North Carolina, United States of Ameri…. Hauptthemen laut MEDLINE: Black or African American, Contraceptives, Oral, Combined, Leiomyoma. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0). Gefördert von: Intramural NIH HHS, NIH, National Institute of Environmental Health Sciences, National Institute of Environmental Health Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Published associations between combined oral contraceptive use and uterine fibroid development have lacked prospective imaging with ultrasound to distinguish between incident and prevalent fibroids. The Study of Environment, Lifestyle, and Fibroids prospectively followed fibroid-free, African-American women (the group with the highest disease burden in the U.S.) to identify incident cases. We examined associations between combined oral contraceptive use and the 40-month cumulative risk of fibroids. History of hormonal contraceptive use was collected via telephone interview at enrollment. Fibroid identification was performed using transvaginal ultrasonography at enrollment, and at 20 and 40-months of follow-up. Inverse probability weights for exposures and censoring were used to construct weighted risk ratios (wRR) and weighted risk different (wRD) estimators which control for differences in fibroid risk factors between exposure groups. In addition, unweighted fully adjusted log-binomial regression models (aRR) were run for comparison. Of the 1,308 participants in the analysis sample, 70% had used combined oral contraceptives and 17% developed fibroids by 40 months. We observed an inverse association between ever use of combined oral contraceptives and cumulative fibroid incidence (wRR: 0.78; 95% Confidence Interval (CI): 0.60, 1.00; wRD: -0.05, 95% CI: -0.11, 0; aRR: 0.76, 95% CI: 0.60, 0.98). Fibroid incidence was greater in participants who started using combined oral contraceptives after age 17 years than among younger initiators, though the restriction to ever-users made this estimate less precise (wRR: 1.25; 95% CI: 0.89, 1.76; wRD: 0.04, 95% CI: -0.02, 0.10). No consistent patterns of fibroid incidence were seen among ever-users for duration of, or years since, last combined oral contraceptives use.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Black or African AmericanContraceptives, Oral, CombinedLeiomyomaAdultFemaleHumansMiddle AgedYoung AdultIncidenceProspective StudiesRisk FactorsUterine NeoplasmsAdolescent

Substanzen

Contraceptives, Oral, Combined

Autor:innen und Institutionen

  • Department of Epidemiology, University of North Carolina Gillings School of Global Public Health, Chapel Hill, North Carolina, United States of America.
  • Department of Biostatistics, University of North Carolina Gillings School of Global Public Health, Chapel Hill, North Carolina, United States of America.
  • Department of Obstetrics and Gynecology, University of North Carolina School of Medicine, Chapel Hill, North Carolina, United States of America.
  • University of North Carolina Center for Women's Health Research, Chapel Hill, North Carolina, United States of America.
  • Program on Women's Endocrine and Reproductive Health, University of North Carolina School of Medicine, Chapel Hill, North Carolina, United States of America.
  • Center for Health Promotion and Disease Prevention, Chapel Hill, North Carolina, United States of America.

ORCID-Profile: Sarah R Hoffman, Quaker E Harmon

Förderung

  • Intramural NIH HHS
  • NIH, National Institute of Environmental Health Sciences
  • National Institute of Environmental Health Sciences
  • American Recovery and Reinvestment Act

Zitieren

APA

Hoffman, S. R., Smith, J. S., Funk, M. J., Hudgens, M. G., Poole, C., Nicholson, W. K., Baird, D. D., & Harmon, Q. E. (2024). Combined oral contraceptive utilization and uterine fibroid incidence: A prospective study in a cohort of African-American women. PLOS ONE, 19(5), e0303823. https://doi.org/10.1371/journal.pone.0303823

Vancouver

Hoffman SR, Smith JS, Funk MJ, Hudgens MG, Poole C, Nicholson WK, et al. Combined oral contraceptive utilization and uterine fibroid incidence: A prospective study in a cohort of African-American women. PLOS ONE. 2024;19(5):e0303823. doi:10.1371/journal.pone.0303823

BibTeX
@article{Hoffman2024,
  author = {Hoffman, Sarah R and Smith, Jennifer S and Funk, Michele Jonsson and Hudgens, Michael G and Poole, Charles and Nicholson, Wanda K and Baird, Donna D and Harmon, Quaker E},
  title = {Combined oral contraceptive utilization and uterine fibroid incidence: A prospective study in a cohort of African-American women},
  journal = {PLOS ONE},
  year = {2024},
  volume = {19},
  number = {5},
  pages = {e0303823},
  doi = {10.1371/journal.pone.0303823}
}
Kostenlos starten →